Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03729232

Japanese Catheter Ablation Registry

Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Catheter Ablation Arrhythmias, Cardiac Cardiac Arrhythmias Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Japanese Cather Ablation (J-AB) Registry is a nationwide, multicenter, observational registry, performed by Japanese Heart Rhythm Society, collaborated with National Cerebral and Cardiovascular Center.

This study is a voluntary nationwide registry and data are collected prospectively using a Research Electronic Data Capture (REDCap) system. Detailed data collection including antiarrhythmic medication is also performed at every September. The acute success rate at discharge and the complications associated with ablation procedure will be collected in all cases. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria. Based on the provided information, the annual incidence and predictive factors for outcome will be investigated by the event assessment committee.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients treated with catheter ablation in Japan

Exclusion criteria

  • Patients who refused to consent

Treatment and study plan

Primary outcomes

  1. Number of patients with recurrence of targeted arrhythmia

    Time frame: Through discharge from hospital, approximately up to 1 weeks

Secondary outcomes

  1. Number of deaths

    Time frame: Through discharge from hospital, approximately up to 1 weeks

    All-cause death, cardiovascular death, and procedure-related death

  2. Number of patients with treatment-related complications

    Time frame: 3 months

    Bleeding events, embolic events, other all complications. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria.

Study contacts

Contact information is provided by the study sponsor or research team.

Kengo Kusano, MD, PhD

CONTACT

[email protected]

+81-6-6170-1070

Misa Takegami, PhD, MPH

CONTACT

[email protected]

+81-6-6170-1070

Sponsors and collaborators

Lead sponsor

National Cerebral and Cardiovascular Center, Japan

Other

Registry information

Acronym: J-AB

Important dates

Study start
2017
Primary completion
2030
Study completion
2030
First posted
Nov 2, 2018
Registry last updated
Nov 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.